• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHIRAKAWA OLYMPUS CO., LTD. EVIS LUCERA ULTRASOUND GASTROVIDEOSCOPE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHIRAKAWA OLYMPUS CO., LTD. EVIS LUCERA ULTRASOUND GASTROVIDEOSCOPE Back to Search Results
Model Number GF-UCT260
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abscess (1690); Pulmonary Emphysema (1832); Failure of Implant (1924); Sepsis (2067); Peritonitis (2252); Pancreatitis (4481); Unspecified Gastrointestinal Problem (4491); Unspecified Hepatic or Biliary Problem (4493)
Event Date 11/30/2022
Event Type  Injury  
Manufacturer Narrative
The suspect device has not been returned to olympus for evaluation.The investigation is in process.The literature article is attached for additional information.Once the investigation has been completed, a supplemental report will be submitted with device evaluation results.
 
Event Description
Olympus reviewed the following literature titled "a retrospective multicenter study comparing the punctures to b2 and b3 in endoscopic ultrasound¿guided hepaticogastrostomy".Objectives: in recent years,endoscopic ultrasound¿guided hepaticogastrostomy (eus¿hgs) has been performed as an important salvage option for failed endoscopic retrograde cholangiopancreatography for biliary drainage.However, technical issues, such as puncture site (bile duct of segment 3 [b3] or bile duct of segment 2 [b2]), dilation method, stent selection, and procedural safety, need to be resolved for the optimization of eus¿hgs.The present study was to compare the safety, difficulty, and technical and functional success between biliary access via b2 and b3 during eus¿hgs.Methods: we conducted a retrospective investigation of 161 consecutive eus¿hgs cases across a total of 6 facilities, including those at our hospital.The patients were divided into two groups according to the successful drainage route: the puncture to b2 (p-b2) or the puncture to b3 (p-b3).We compared the technical and functional success rates, technical difficulty, and adverse events between the two groups.We also conducted a subgroup analysis to show the factors related to the procedure time.Results: there were 92 cases in the p-b2 group and 69 cases in the p-b3 group.There were no significant differences in the technical success, functional success,or adverse events between the groups;however,the procedure time was significantly shorter in p-b2 cases than in p-b3 cases.The multivariate analysis showed that the puncture site was the only factor related to the procedure time.Conclusions: based on these findings, p-b2 appears useful and safe.P-b2 is as effective as p-b3 and was able to be performed in a shorter period of time.The b2 approach can be considered a useful option for eus¿hgs.Type of adverse events/number of patients: mediastinal emphysema (n=1); sepsis (n=4); ulceration (n=1); bleeding (n=4); peritonitis (n=6); bile leakage (n=4); pancreatitis (n=1); stent slippage (n=3); stent migration (n=1); liver abscess (n=2).This literature article requires 3 reports.The related patient identifiers are as follows: 1.(b)(6) (for gf-uct240-al5); 2.(b)(6) (for gf-uct260); 3.(b)(6) (for single use biliary drainage stent v).This medwatch report is for patient identifier (b)(6).There is no report of any olympus device malfunction in any procedure described in this study.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVIS LUCERA ULTRASOUND GASTROVIDEOSCOPE
Type of Device
ULTRASOUND GASTROVIDEOSCOPE
Manufacturer (Section D)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA  961-8061
Manufacturer (Section G)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA   961-8061
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key16341992
MDR Text Key309261646
Report Number3002808148-2023-01242
Device Sequence Number1
Product Code ODG
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 02/09/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/09/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGF-UCT260
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
-
-